6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride has been researched along with arachidonic acid in 2 studies
Studies (6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride) | Trials (6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride) | Recent Studies (post-2010) (6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride) | Studies (arachidonic acid) | Trials (arachidonic acid) | Recent Studies (post-2010) (arachidonic acid) |
---|---|---|---|---|---|
8 | 0 | 0 | 19,295 | 486 | 3,040 |
Protein | Taxonomy | 6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride (IC50) | arachidonic acid (IC50) |
---|---|---|---|
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 4.5 | |
Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 2.75 | |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 4.5 | |
60 kDa chaperonin | Escherichia coli | 7.3 | |
10 kDa chaperonin | Escherichia coli | 7.3 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.0715 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.6026 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giessler, C; Heinroth-Hoffmann, I; Mest, HJ | 1 |
Hauser, A; Heinroth-Hoffmann, I; Mest, HJ | 1 |
2 other study(ies) available for 6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride and arachidonic acid
Article | Year |
---|---|
Relevance of vasoactive mediators for the blood pressure effects of intravenous arachidonic acid injection in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Aspirin; Blood Pressure; Cyproheptadine; Diterpenes; Ginkgolides; Imidazoles; Injections, Intravenous; Lactones; Male; Naphthalenes; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane B2 | 1992 |
Effects of platelet activating factor antagonists on arachidonic acid-induced platelet aggregation and TXA2 formation.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Azepines; Blood Platelets; Diterpenes; Ginkgolides; Imidazoles; In Vitro Techniques; Lactones; Naphthalenes; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase; Triazoles | 1990 |